Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2—Discovery of LRRK2 inhibitors
Authors:
- 15 September 2010
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 404 (2) , 186-192
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase ActivitiesBiochemistry, 2010
- Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019SJournal of Neuroscience, 2010
- Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal MorphogenesisThe Journal of Neuroscience, 2009
- Investigation of leucine‐rich repeat kinase 2The FEBS Journal, 2008
- Kinetic Studies of Cdk5/p25 Kinase: Phosphorylation of Tau and Complex Inhibition by Two Prototype InhibitorsBiochemistry, 2008
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular AutophosphorylationJournal of Biological Chemistry, 2008
- LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityBiochemical Journal, 2007
- Leucine‐rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutantsJournal of Neurochemistry, 2007
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- Parkinson's DiseaseNeuron, 2003